1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Human iPSCs 1.2.3 Mouse iPSCs 1.3 Market by Application 1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Academic Research 1.3.3 Drug Development and Discovery 1.3.4 Toxicity Screening 1.3.5 Regenerative Medicine 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2016-2027) 2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions 2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Induced Pluripotent Stem Cells (iPSCs) Historic Market Share by Regions (2016-2021) 2.2.3 Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2022-2027) 2.3 Induced Pluripotent Stem Cells (iPSCs) Industry Dynamic 2.3.1 Induced Pluripotent Stem Cells (iPSCs) Market Trends 2.3.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers 2.3.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges 2.3.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue 3.1.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2016-2021) 3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2016-2021) 3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue 3.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio 3.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2020 3.5 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served 3.6 Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service 3.7 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type 4.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2016-2021) 4.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2022-2027) 5 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application 5.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2016-2021) 5.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027) 6.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type 6.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) 6.2.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) 6.2.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027) 6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application 6.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) 6.3.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) 6.3.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027) 6.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country 6.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) 6.4.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027) 7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type 7.2.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) 7.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) 7.2.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027) 7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application 7.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) 7.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) 7.3.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027) 7.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country 7.4.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) 7.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027) 8.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type 8.2.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027) 8.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application 8.3.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027) 8.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region 8.4.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027) 9.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type 9.2.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) 9.2.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) 9.2.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027) 9.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application 9.3.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) 9.3.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) 9.3.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027) 9.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country 9.4.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) 9.4.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027) 10.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type 10.2.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027) 10.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application 10.3.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027) 10.4 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country 10.4.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Fujifilm Holding Corporation (CDI) 11.1.1 Fujifilm Holding Corporation (CDI) Company Details 11.1.2 Fujifilm Holding Corporation (CDI) Business Overview 11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction 11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.1.5 Fujifilm Holding Corporation (CDI) Recent Development 11.2 Ncardia 11.2.1 Ncardia Company Details 11.2.2 Ncardia Business Overview 11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction 11.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.2.5 Ncardia Recent Development 11.3 Sumitomo Dainippon Pharma 11.3.1 Sumitomo Dainippon Pharma Company Details 11.3.2 Sumitomo Dainippon Pharma Business Overview 11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction 11.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.3.5 Sumitomo Dainippon Pharma Recent Development 11.4 Astellas Pharma Inc 11.4.1 Astellas Pharma Inc Company Details 11.4.2 Astellas Pharma Inc Business Overview 11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction 11.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.4.5 Astellas Pharma Inc Recent Development 11.5 Fate Therapeutics, Inc 11.5.1 Fate Therapeutics, Inc Company Details 11.5.2 Fate Therapeutics, Inc Business Overview 11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction 11.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.5.5 Fate Therapeutics, Inc Recent Development 11.6 Pluricell Biotech 11.6.1 Pluricell Biotech Company Details 11.6.2 Pluricell Biotech Business Overview 11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction 11.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.6.5 Pluricell Biotech Recent Development 11.7 Cell Inspire Biotechnology 11.7.1 Cell Inspire Biotechnology Company Details 11.7.2 Cell Inspire Biotechnology Business Overview 11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction 11.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.7.5 Cell Inspire Biotechnology Recent Development 11.8 ReproCELL 11.8.1 ReproCELL Company Details 11.8.2 ReproCELL Business Overview 11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction 11.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) 11.8.5 ReproCELL Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Human iPSCs Table 3. Key Players of Mouse iPSCs Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2016-2021) Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2022-2027) Table 10. Induced Pluripotent Stem Cells (iPSCs) Market Trends Table 11. Induced Pluripotent Stem Cells (iPSCs) Market Drivers Table 12. Induced Pluripotent Stem Cells (iPSCs) Market Challenges Table 13. Induced Pluripotent Stem Cells (iPSCs) Market Restraints Table 14. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2016-2021) Table 16. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2020) Table 17. Ranking of Global Top Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service Table 21. Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million) Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2016-2021) Table 25. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2016-2021) Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million) Table 32. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million) Table 34. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million) Table 61. Fujifilm Holding Corporation (CDI) Company Details Table 62. Fujifilm Holding Corporation (CDI) Business Overview Table 63. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Table 64. Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 65. Fujifilm Holding Corporation (CDI) Recent Development Table 66. Ncardia Company Details Table 67. Ncardia Business Overview Table 68. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Table 69. Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 70. Ncardia Recent Development Table 71. Sumitomo Dainippon Pharma Company Details Table 72. Sumitomo Dainippon Pharma Business Overview Table 73. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Table 74. Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 75. Sumitomo Dainippon Pharma Recent Development Table 76. Astellas Pharma Inc Company Details Table 77. Astellas Pharma Inc Business Overview Table 78. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Table 79. Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 80. Astellas Pharma Inc Recent Development Table 81. Fate Therapeutics, Inc Company Details Table 82. Fate Therapeutics, Inc Business Overview Table 83. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Table 84. Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 85. Fate Therapeutics, Inc Recent Development Table 86. Pluricell Biotech Company Details Table 87. Pluricell Biotech Business Overview Table 88. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Table 89. Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 90. Pluricell Biotech Recent Development Table 91. Cell Inspire Biotechnology Company Details Table 92. Cell Inspire Biotechnology Business Overview Table 93. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Table 94. Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 95. Cell Inspire Biotechnology Recent Development Table 96. ReproCELL Company Details Table 97. ReproCELL Business Overview Table 98. ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million) Table 99. ReproCELL Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2020 VS 2027 Figure 2. Human iPSCs Features Figure 3. Mouse iPSCs Features Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2020 VS 2027 Figure 5. Academic Research Case Studies Figure 6. Drug Development and Discovery Case Studies Figure 7. Toxicity Screening Case Studies Figure 8. Regenerative Medicine Case Studies Figure 9. Others Case Studies Figure 10. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions: 2020 VS 2027 Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2022-2027) Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2020 Figure 16. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2020 Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2016-2021) Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2022-2027) Figure 20. North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027) Figure 22. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027) Figure 23. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027) Figure 24. United States Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027) Figure 28. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027) Figure 29. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027) Figure 30. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027) Figure 38. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027) Figure 39. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2016-2027) Figure 40. China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027) Figure 48. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027) Figure 49. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027) Figure 50. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027) Figure 54. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027) Figure 55. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027) Figure 56. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 60. Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 61. Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 62. Astellas Pharma Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 63. Fate Therapeutics, Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 64. Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 65. Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 66. ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Fujifilm Holding Corporation (CDI) Ncardia Sumitomo Dainippon Pharma Astellas Pharma Inc Fate Therapeutics, Inc Pluricell Biotech Cell Inspire Biotechnology ReproCELL